A-Z List of ARI Programs Adult AIDS Clinical Trials Group (AACTG) AIDS Action Network (UCSF student AIDS advocacy group) AIDS and Cancer Specimen Resource (ACSR) AIDS Education and Training Centers (AETC) National Resource Center AIDS Health Project AIDS Policy Research Center AIDS Research Institute at UCSF Laboratory of Clinical Virology AIDS Specimen Bank

ASPIRE (AIDS Services—Prevention, Interventions, Research, and Education) Bay Area Perinatal AIDS Center (BAPAC) Blood Systems Research Institute (BSRI) Center for AIDS Prevention Studies (CAPS) Center for HIV Information (CHI) Cochrane Collaborative Review Group on HIV Infection and AIDS Community Consortium Craik Laboratory Drug Research Unit at San Francisco General Hospital FACES (Family AIDS Care and Education Services) Family Treatment Fund Francis J. Curry National TB Center General Clinical Research Center (GCRC) at SFGH Gladstone Institute of Neurological Disease Gladstone Institute of Virology and Immunology HIV InSite Institute for Global Health Intl Center of HIV/AIDS Research & Clinical Training in Nursing International Training and Education Center on HIV (I-TECH) Laboratory for Molecular Pathogenesis Laboratory of Raul Andino Laboratory of Tumor and AIDS Virus Research Moffitt/Mt. Zion General Clinical Research Genter (GCRC) National HIV/AIDS Clinicians' Consultation Center (NCCC) Options Project Osher Center for Integrative Medicine Pacific AIDS Education and Training Center (PAETC) Pediatric Clinical Research Center Positive Health Program at SFGH Positive Health Program Education Unit San Francisco Area (UCSF) AIDS Education and Training Center (AETC) San Francisco Department of Public Health, AIDS Office San Francisco Department of Public Health, HIV Research Section 360: The Positive Care Center at UCSF UCSF Global Health Sciences UCSF Nursing HIV/AIDS Center UCSF-GIVI Center for AIDS Research (CFAR) Women's Global Health Imperative Women's HIV Interdisciplinary Network Women's HIV Program at UCSF Women's Interagency HIV Study (WIHS)

ari scientists

Jeffrey N. Martin, MD, MPH

Jeffrey N. Martin, MD, MPH, is assistant professor in the Department of Epidemiology and Biostatistics at UCSF and the Department of Medicine at San Francisco General Hospital. Dr. Martin received his undergraduate degree at the Johns Hopkins University, his medical degree at the University of Pennsylvania, and his master's degree in public health (with an epidemiology focus) at the University of California, Berkeley. Dr. Martin is currently the associate director of the Behavioral Science and Epidemiology Core of the UCSF-GIVI Center for AIDS Research and was until recently co-director of the Data and Biostatistical Analysis Coordinating Center Core of the California AIDS Research Center at UCSF. In addition, he is co-director of the UCSF Training in Clinical Research Program, director of the Advanced Training in Clinical Research Certificate Program, and director of the forthcoming master's degree program in clinical research. Dr. Martin is board-certified in internal medicine and infectious diseases and attends at the San Francisco General Hospital.

Dr. Martin's research has included evaluating the role of older age on survival in HIV disease, the impact of HIV disease on the development of drug-resistant tuberculosis, the emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era, and the effectiveness of mupirocin in eradicating Staphylococcus aureus in HIV-infected patients. He has had extensive experience with large observational cohort studies, including the San Francisco Men's Health Study, and the population-based tuberculosis registry in San Francisco. Dr. Martin's current research interests are in the areas of the epidemiology of human herpesvirus 8/Kaposi's sarcoma–associated herpesvirus (KSHV), the long-term consequences of highly active antiretroviral therapy for HIV infection, post-exposure prophylaxis against HIV infection after sexual or injection drug use exposure, and adherence to antiretroviral therapy. In these studies, Dr. Martin and his colleagues are following over 1500 HIV-infected patients and persons at risk for HIV infection.